Gastrostomy Tube Feeding Devices Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032

Gastrostomy Tube Feeding Devices Market Size

Gastrostomy Tube Feeding Devices Market size is poised to exhibit a steady growth rate between 2024 and 2032 driven by the growing geriatric population, coupled with the high incidences of chronic conditions globally. The imperative to reduce mortality rates, ICU admissions, and hospital stays, coupled with the recognition of inadequate nutrition's detrimental effects, is encouraging healthcare institutions to prioritize the early provision of enteral nutrition to critically ill hospitalized patients.
 

There is surge in adoption of percutaneous endoscopic gastrostomy devices for their ease of use compared to nasogastric tubes, as they are inserted directly through the stomach to deliver food to the intestine. Additionally, their convenience extends to outpatient procedures, where overnight stays are not necessary, further contributing to their increasing adoption.
 

Gastrostomy Tube Feeding Devices Market Trends

There is a growing demand for advanced gastrostomy tube feeding devices with enhanced functionality, such as adjustable flow rates, bolus feeding capabilities, and built-in safety features, to meet the diverse nutritional needs of patients. Furthermore, technological advancements, including the integration of wireless connectivity and smart features in gastrostomy tube feeding devices, are enabling remote monitoring and personalized patient care, improving treatment outcomes and patient satisfaction. As healthcare providers increasingly prioritize patient comfort, safety, and convenience, the industry dynamics will be influenced positively by innovations.
 

Gastrostomy Tube Feeding Devices Market Analysis

By age group, the pediatrics segment is likely to hold a substantial share in market over the forecast period, owing to the rising number of premature births worldwide. According to the World Health Organization, an estimated 15 million infants are born prematurely each year (before the completion of 37 weeks of gestation) and preterm birth complications are the leading cause of death among children below the age of five. The prevalence of feeding challenges among premature and medically fragile infants drives the product usage.
 

The neurological disorders segment is expected to record a notable increase in revenue by 2032. Weight loss and malnutrition are common among patients with motor neuron disease, Alzheimer’s, Parkinson’s, and other neurological disorders. To minimize the risk of mortality, morbidity, and disability amongst these patients, interventional nutritional support using these feeding devices is recommended by healthcare personnel.
 

Europe gastrostomy tube feeding devices market size is anticipated to grow substantially through 2032 owing to the expanding geriatric population across Germany, the U.K., Sweden, Bulgaria, and Italy. The high burden of cancer across EU countries is facilitating product uptake for the enteral feeding application. Malnutrition is prevalent among cancer patients, exacerbated by the impact of treatments including chemotherapy, surgery, or radiation therapy. The challenge of maintaining adequate nutrition in the context of cancer care, particularly for patients with tumors affecting the neck or head region, leading to swallowing difficulties.
 

Additionally, diagnoses such as fistulas or esophageal abscesses further complicate digestion, underscoring the demand for solutions to support nutritional needs in this patient population. The increasing cases of fistulas will also augment the regional industry expansion.
 

Gastrostomy Tube Feeding Devices Market Share

Some leading manufacturers of gastrostomy tube feeding devices are.

• Moog
• Boston Scientific Corporation
• Abbott Nutrition
• Halyard Health
• C.R. Bard
• Fresenius Kabi
• Medtronic
• Nestle
• Danone
   

Gastrostomy Tube Feeding Devices Industry News

In November 2021, Omnicell, Inc., a top provider of medication management solutions, and Fresenius Kabi, a global healthcare company specializing in transfusion, infusion, and clinical nutrition, teamed up to offer cutting-edge pharmacy technology to U.S. hospitals. The collaboration aimed to enhance safety and efficiency in dispensing controlled substances in patient care areas.

What Information does this report contain?